RBF Ventures, LLC – Trademark Portfolio
Entity Type: 16
RBF Ventures, LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 6 Nice Classification classes. Currently, 0 trademarks are registered and 7 are pending. The owner is based in Chicago, IL.
Unit 515
845 N. Kingsbury
Chicago, IL 60610
Showing of trademarks Trademarks
Trademark Classifications
RBF Ventures, LLC's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does RBF Ventures, LLC have?
RBF Ventures, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 7 pending, 1 abandoned, 1 cancelled.
What trademark classes does RBF Ventures, LLC file in?
RBF Ventures, LLC files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 30 (Staple Foods), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is RBF Ventures, LLC's trademark registration success rate?
RBF Ventures, LLC has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 7 applications are pending review.